Your session is about to expire
← Back to Search
One-Legged vs Two-Legged Cycle Training for Idiopathic Pulmonary Fibrosis
N/A
Recruiting
Led By Roger S Goldstein
Research Sponsored by West Park Healthcare Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Clinically stable
Confirmed idiopathic pulmonary fibrosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at discharge from 8 weeks of pulmonary rehabilitation
Awards & highlights
Study Summary
This trial will compare the effects of one-legged versus two-legged exercise training in patients with idiopathic pulmonary fibrosis.
Who is the study for?
This trial is for stable patients with confirmed idiopathic pulmonary fibrosis who are enrolled in a pulmonary rehab program. It's not suitable for those who've had a recent exacerbation, finished rehab within the last 6 months, or have other health issues that could make rehab unsafe.Check my eligibility
What is being tested?
The study tests if exercising one leg at a time can improve endurance more than the usual two-leg cycling for people with IPF. The idea is to reduce breathing demand during exercise by working fewer muscles simultaneously.See study design
What are the potential side effects?
While specific side effects aren't listed, exercise interventions like these may cause muscle soreness, fatigue, and shortness of breath especially in individuals with lung conditions such as IPF.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My health condition is currently stable.
Select...
I have been diagnosed with idiopathic pulmonary fibrosis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at discharge from 8 weeks of pulmonary rehabilitation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at discharge from 8 weeks of pulmonary rehabilitation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cycle exercise endurance time
Secondary outcome measures
health-related quality of life
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: intervention -1-leg cycle trainingExperimental Treatment1 Intervention
Primary aerobic training component one-legged, partitioned, cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity one-legged exercise progressing to continuous duration of the target duration of 15 min for each leg and then restarting the cycle at a higher intensity.
Group II: usual care - 2-leg cycle trainingActive Control1 Intervention
Primary aerobic training component conventional two-legged cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity exercise progressing to continuous duration of 30 min and then restarting the cycle at a higher intensity.
Find a Location
Who is running the clinical trial?
West Park Healthcare CentreLead Sponsor
31 Previous Clinical Trials
2,208 Total Patients Enrolled
Roger S GoldsteinPrincipal InvestigatorWest Park Healthcare Centre
1 Previous Clinical Trials
6 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My health condition is currently stable.You had a worsening of your condition within six weeks before joining the study.I have been diagnosed with idiopathic pulmonary fibrosis.I have health issues that may make it unsafe for me to do lung rehab exercises.I finished a lung rehab program in the last 6 months.You are currently participating in a program to help improve your lung function.
Research Study Groups:
This trial has the following groups:- Group 1: intervention -1-leg cycle training
- Group 2: usual care - 2-leg cycle training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there currently any openings for participants in this clinical trial?
"The study has been posted on clinicaltrials.gov since March 1st 2019 and was recently updated on January 22nd 2022, indicating it is currently looking for patients to enrol."
Answered by AI
How many individuals have signed up for this research endeavor?
"Affirmative. Clinicaltrials.gov's information indicates that, since it was initially posted on 3rd of March 2019, this clinical trial is actively seeking patients to participate in the study. 50 participants are needed at a single medical site for enrollment."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger